Striking the right balance between innovation and drug price competition: understanding the Hatch-Waxman Act--an introduction of speakers.
Rea
T S
TS
Burns, Doane, Swecker & Mathis, LLP, Alexandria, VA, USA
D003226:Congresses as Topic; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D004465:Economic Competition; D006801:Humans; D017387:Investigational New Drug Application; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D014481:United States
D016568:Drugs, Generic